Skip to main content

Teleflex Incorporated

corporate_fare Company Profile

Teleflex Incorporated

TFX·NYSE·Industrial Applications And Services·CIK 0000096943

Teleflex Incorporated is a global provider of medical technology products designed to enhance clinical benefits, improve patient and provider safety, and reduce total procedural costs. The company primarily designs, develops, manufactures, and supplies single-use medical devices. These devices are used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Teleflex markets and sells its products to hospitals and healthcare providers worldwide through a combination of its direct sales force and distributors. The company is not dependent upon any single end-market or procedure due to the diverse applications of its products. Major manufacturing operations are located in the Czech Republic, Malaysia, Mexico, and the United States. Teleflex aims for consistent, sustainable, and profitable growth and improved financial performance by increasing market share and operating efficiencies. This is pursued through developing new products and product line extensions, investing in new technologies, expanding product use in existing markets and introducing them into new geographic markets, achieving economies of scale, and expanding its product portfolio via select acquisitions, licensing arrangements, and business partnerships. The company's research and development capabilities, engineering focus, and low-cost manufacturing enable it to bring cost-effective, innovative products to market that improve healthcare safety, efficacy, and quality. Research and development initiatives focus on new therapeutic applications, as well as enhancements and product line extensions for existing products.

Teleflex Incorporated (NYSE:TFX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 26 items for TFX at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Teleflex Defends Strategy Against Activist, Confirms $1.8B Divestiture Proceeds for $1B Buyback & Debt Paydown, $50M Cost Savings
  • Teleflex Divestiture Faces FTC Scrutiny, One Deal Clears HSR
  • Teleflex Reports Massive Net Loss Driven by $1.3B Impairments and Strategic Divestitures; Authorizes $1B Share Buyback
  • Teleflex Reports 2025 Results, Issues 2026 Guidance with Restructuring Plan & Substantial Capital Return
  • Teleflex Finalizes Separation Terms for Former CEO Liam Kelly

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.99B
Net Income
-$905.64M
Diluted EPS
-$20.25
Gross Profit
$1.12B
Operating Income
$118.37M
Cash & Equivalents
$378.56M
Total Debt
$2.64B
Debt / Equity
0.85×
Net Margin
-45.4%
Shares Outstanding
44.62M sh
Source: 10-K · filed 2026-02-27 · accession 0000096943-26-000019
$124.5 -0.02% today
52-week range · as of 2026-08-07 $100.18 – $145
Market cap
$5.28B
Volume
1.8M (2.7× avg)
3-mo avg 668.4K
Live data · 2026-09-20 14:23 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TFX - Filings & News (Page 2)

TFX
Mar 27, 2026, 2:48 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $116.27
Real-time Price: $124.50 info
Change: +$8.23 (+7%) info
Market Cap: $5.276B info
TFX
Mar 17, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $109.00
Real-time Price: $124.50 info
Change: +$15.50 (+14%) info
Market Cap: $5.276B info
TFX
Feb 27, 2026, 4:11 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $122.06
Real-time Price: $124.50 info
Change: +$2.44 (+2%) info
Market Cap: $5.276B info
TFX
Feb 26, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $101.05
Real-time Price: $124.50 info
Change: +$23.45 (+23%) info
Market Cap: $5.276B info
TFX
Jan 23, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $103.40
Real-time Price: $124.50 info
Change: +$21.10 (+20%) info
Market Cap: $5.276B info
TFX
Jan 08, 2026, 6:55 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $124.65
Real-time Price: $124.50 info
Change: -$0.150 (-0.12%) info
Market Cap: $5.276B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets